Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease (DETECT)
This study is currently recruiting participants.
Study NCT00553969   Information provided by University of Minnesota
First Received: November 5, 2007   Last Updated: June 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pre-Hypertension
Additional conditions recognized in this trial
Cardiovascular Diseases
Hypertension
More general conditions related to this trial
Vascular Diseases
Interventions listed in this trial
carvedilol phosphate
lisinopril
carvedilol phosphate and lisinopril
Additional drug interventions recognized in this trial
Carvedilol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiotonic Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Minnesota
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services